Allogene Therapeutics Reports First Quarter 2020 Financial Results

Go back to Allogene Therapeutics Reports First Quarter 2020 Financial Results
(NASDAQ: ALLO) Delayed: 2.00 -0.1 (4.76%)
Previous Close $2.10    52 Week High
Open $2.10    52 Week Low
Day High $2.10    P/E N/A 
Day Low $1.94    EPS
Volume 5,637,434